Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Lappas, Martha ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN SYNTHASE; SIRTUIN 6; VASCULOTROPIN; SIRT6 PROTEIN, HUMAN; SIRTUIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; GENE LOSS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

CELL ADHESION; CELL MOVEMENT; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; SIRTUINS;

EID: 84870203841     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/597514     Document Type: Article

References (47)

1. Csiszar A., Wang M., Lakatta E. G., Ungvari Z., Inflammation and endothelial dysfunction during aging: role of NF- κ B. Journal of Applied Physiology 2008 105 4 1333 1341 2-s2.0-55449136486 10.1152/japplphysiol.90470. 2008
2. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
3. De Vriese A. S., Verbeuren T. J., Van De Voorde J., Lameire N. H., Vanhoutte P. M., Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000 130 5 963 974 2-s2.0-0033920419 (Pubitemid 30453529)
4. Szabó C., Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A. L., Endothelial dysfunction in a rat model of endotoxic shock: importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. Journal of Clinical Investigation 1997 100 3 723 735 2-s2.0-0030854951 (Pubitemid 27340522)
5. Schouten M., Wiersinga W. J., Levi M., Van Der Poll T., Inflammation, endothelium, and coagulation in sepsis. Journal of Leukocyte Biology 2008 83 3 536 545 2-s2.0-43349096795 10.1189/jlb.0607373 (Pubitemid 351966862)
6. Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., Ono M., Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB Journal 2004 18 2 300 310 2-s2.0-0442277878 10.1096/fj.03-0473com (Pubitemid 38186249)
7. Szekanecz Z., Koch A. E., Mechanisms of disease: angiogenesis in inflammatory diseases. Nature Clinical Practice Rheumatology 2007 3 11 635 643 2-s2.0-35648933951 10.1038/ncprheum0647 (Pubitemid 350031753)
8. Sprague A. H., Khalil R. A., Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology 2009 78 6 539 552 2-s2.0-67651146363 10.1016/j.bcp.2009.04.029
9. Tedgui A., Mallat Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006 86 2 515 581 2-s2.0-33645891172 10.1152/physrev.00024.2005
10. Galkina E., Ley K., Vascular adhesion molecules in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 11 2292 2301 2-s2.0-36048979880 10.1161/ATVBAHA.107.149179 (Pubitemid 350203942)
11. Michishita E., Park J. Y., Burneskis J. M., Barrett J. C., Horikawa I., Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Molecular Biology of the Cell 2005 16 10 4623 4635 2-s2.0-26244436281 10.1091/mbc.E05-01-0033 (Pubitemid 41416446)
12. Potente M., Ghaeni L., Baldessari D., Mostoslavsky R., Rossig L., Dequiedt F., Haendeler J., Mione M., Dejana E., Alt F. W., Zeiher A. M., Dimmeler S., SIRT1 controls endothelial angiogenic functions during vascular growth. Genes and Development 2007 21 20 2644 2658 2-s2.0-35348980724 10.1101/gad.435107 (Pubitemid 47607673)
13. Stein S., Matter C. M., Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011 10 4 640 647 2-s2.0-79951881254 10.4161/cc.10.4.14863
14. Kaur G., Roberti M., Raul F., Pendurthi U. R., Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol. Thrombosis Research 2007 119 2 247 256 2-s2.0-33751082988 10.1016/j.thromres.2006.01.020 (Pubitemid 44765074)
15. Csiszar A., Labinskyy N., Pinto J. T., Ballabh P., Zhang H., Losonczy G., Pearson K., De Cabo R., Pacher P., Zhang C., Ungvari Z., Resveratrol induces mitochondrial biogenesis in endothelial cells. American Journal of Physiology 2009 297 1 H13 H20 2-s2.0-67650091375 10.1152/ajpheart.00368.2009
16. Do G. M., Kwon E. Y., Kim H. J., Jeon S. M., Ha T. Y., Park T., Choi M. S., Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochemical and Biophysical Research Communications 2008 374 1 55 59 2-s2.0-47749085845 10.1016/j.bbrc.2008.06.113
17. Das S., Alagappan V. K. T., Bagchi D., Sharma H. S., Maulik N., Das D. K., Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascular Pharmacology 2005 42 5-6 281 289 2-s2.0-19444364321 10.1016/j.vph.2005.02.013 (Pubitemid 40726331)
18. Zhang Q. J., Wang Z., Chen H. Z., Zhou S., Zheng W., Liu G., Wei Y. S., Cai H., Liu D. P., Liang C. C., Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovascular Research 2008 80 2 191 199 2-s2.0-54149103338 10.1093/cvr/cvn224
19. Baur J. A., Sinclair D. A., Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 2006 5 6 493 506 2-s2.0-33745962138 10.1038/nrd2060 (Pubitemid 44136961)
20. Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N., Swindell W. R., Kamara D., Minor R. K., Perez E., Jamieson H. A., Zhang Y., Dunn S. R., Sharma K., Pleshko N., Woollett L. A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P. J., Becker K. G., Navas P., Ingram D. K., Wolf N. S., Ungvari Z., Sinclair D. A., de Cabo R., Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 2008 8 2 157 168 2-s2.0-48349144852 10.1016/j.cmet.2008.06.011
21. Kawahara T. L. A., Michishita E., Adler A. S., Damian M., Berber E., Lin M., McCord R. A., Ongaigui K. C. L., Boxer L. D., Chang H. Y., Chua K. F., SIRT6 links histone H3 lysine 9 deacetylation to NF- κ B-dependent gene expression and organismal life span. Cell 2009 136 1 62 74 2-s2.0-58149090925 10.1016/j.cell.2008.10.052
22. Lappas M., Mitton A., Lim R., Barker G., Riley C., Permezel M., SIRT1 is a novel regulator of key pathways of human labor. Biology of Reproduction 2011 84 1 167 178 2-s2.0-78651511093 10.1095/biolreprod.110.086983
23. Libby P., Ridker P. M., Maseri A., Inflammation and atherosclerosis. Circulation 2002 105 9 1135 1143 2-s2.0-0037022910 10.1161/hc0902.104353 (Pubitemid 34212626)
24. Shen Z., Ajmo J. M., Rogers C. Q., Liang X., Le L., Murr M. M., Peng Y., You M., Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF- α production in cultured macrophage cell lines. American Journal of Physiology 2009 296 5 G1047 G1053 2-s2.0-66149115196 10.1152/ajpgi.00016.2009
25. Yuan Q., Chen L., Xiang D. X., Li Y. J., Hu C. P., Effect of resveratrol derivative BTM-0512 on high glucose-induced dysfunction of endothelial cells: role of SIRT1. Canadian Journal of Physiology and Pharmacology 2011 89 713 722
26. Van Gool F., Gallí M., Gueydan C., Kruys V., Prevot P. P., Bedalov A., Mostoslavsky R., Alt F. W., De Smedt T., Leo O., Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nature Medicine 2009 15 2 206 210 2-s2.0-59649117804 10.1038/nm.1906
27. Minagawa S., Araya J., Numata T., Nojiri S., Hara H., Yumino Y., Kawaishi M., Odaka M., Morikawa T., Nishimura S. L., Nakayama K., Kuwano K., Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF- β -induced senescence of human bronchial epithelial cells. American Journal of Physiology 2011 300 3 L391 L401 2-s2.0-79955047394 10.1152/ajplung.00097. 2010
28. Carmeliet P., Jain R. K., Angiogenesis in cancer and other diseases. Nature 2000 407 6801 249 257 2-s2.0-0034648765 10.1038/35025220
29. Carmeliet P., Angiogenesis in life, disease and medicine. Nature 2005 438 7070 932 936 2-s2.0-30744479430 10.1038/nature04478 (Pubitemid 43093958)
30. Griffioen A. W., Molema G., Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacological Reviews 2000 52 2 237 268 2-s2.0-0034090097 (Pubitemid 30368433)
31. Natarajan R., Nadler J. L., Lipid inflammatory mediators in diabetic vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 9 1542 1548 2-s2.0-4444350561 10.1161/01.ATV.0000133606.69732.4c (Pubitemid 39180875)
32. Feletou M., Huang Y., Vanhoutte P. M., Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. British Journal of Pharmacology 2011 164 894 912
33. Davidge S. T., Prostaglandin H synthase and vascular function. Circulation Research 2001 89 8 650 660 2-s2.0-0035851212 (Pubitemid 34627064)
34. Galis Z. S., Khatri J. J., Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 2002 90 3 251 262 2-s2.0-0037155057 (Pubitemid 34633925)
35. Sluijter J. P. G., De Kleijn D. P. V., Pasterkamp G., Vascular remodeling and protease inhibition-bench to bedside. Cardiovascular Research 2006 69 3 595 603 2-s2.0-31344462860 10.1016/j.cardiores.2005.11.026 (Pubitemid 43139723)
36. Lijnen H. R., Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 2005 3 1 35 45 2-s2.0-18844375381 10.1111/j.1538-7836.2004.00827.x (Pubitemid 41647113)
37. Stefansson S., McMahon G. A., Petitclerc E., Lawrence D. A., Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Current Pharmaceutical Design 2003 9 19 1545 1564 2-s2.0-0037967300 (Pubitemid 36763492)
38. Li L., Zhang H. N., Chen H. Z., Gao P., Zhu L. H., Li H. L., Lv X., Zhang Q. J., Zhang R., Wang Z., She Z. G., Wei Y. S., Du G. H., Liu D. P., Liang C. C., SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circulation Research 2011 108 10 1180 1189 2-s2.0-79957463838 10.1161/CIRCRESAHA.110.237875
39. Li X. C., Zhuo J. L., Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Current Opinion in Nephrology and Hypertension 2008 17 37 43 (Pubitemid 350295195)
40. Liang C. J., Wang S. H., Chen Y. H., Chang S. S., Hwang T. L., Leu Y. L., Tseng Y. C., Li C. Y., Chen Y. L., Viscolin reduces VCAM-1 expression in TNF- α -treated endothelial cells via the JNK/NF- κ B and ROS pathway. Free Radical Biology and Medicine 2011 51 1337 1346 2-s2.0-79960675874 10.1016/j.freeradbiomed.2011.06.023
41. Breitenstein A., Stein S., Holy E. W., Camici G. G., Lohmann C., Akhmedov A., Spescha R., Elliott P. J., Westphal C. H., Matter C. M., Lscher T. F., Tanner F. C., Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovascular Research 2011 89 2 464 472 2-s2.0-78751516833 10.1093/cvr/cvq339
42. Van Gaal L. F., Mertens I. L., De Block C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 7121 875 880 2-s2.0-33845914986 10.1038/nature05487 (Pubitemid 46028447)
43. Kim J. A., Montagnani M., Kwang K. K., Quon M. J., Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 15 1888 1904 2-s2.0-33646178955 10.1161/CIRCULATIONAHA.105.563213 (Pubitemid 43739401)
44. Kerekes G., Soltesz P., Nurmohamed M. T., Gonzalez-Gay M. A., Turiel M., Edit V., Shoenfeld Y., McInnes I., Szekanecz Z., Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nature Reviews Rheumatolog 2012 8 224 234
45. Caricilli A. M., Picardi P. K., de Abreu L. L., Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLOS Biology 2011 9 e1001212
46. Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., Feldstein A. E., Britt E. B., Fu X., Chung Y. M., Wu Y., Schauer P., Smith J. D., Allayee H., Tang W. H. W., Didonato J. A., Lusis A. J., Hazen S. L., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011 472 7341 57 63 2-s2.0-79953733693 10.1038/nature09922
47. Koren O., Spor A., Felin J., Fåk F., Stombaugh J., Tremaroli V., Behre C. J., Knight R., Fagerberg B., Ley R. E., Bäckhed F., Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2011 108 1, supplement 4592 4598 2-s2.0-79952758083 10.1073/pnas.1011383107